Drug Approval | November 21, 2025
FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
The results demonstrated meaningful reductions in the severity of involuntary movements and notable improvements in patient-reported quality of life
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
Subscribe To Our Newsletter & Stay Updated
